Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.

@article{Burggasser2003OrbitalSW,
  title={Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.},
  author={Georg Burggasser and Ingrid Hurtl and Wolfgang Hauff and Julius R Lukas and Michaela Greifeneder and Bamdad Heydari and A. I. Thaler and Andreas Wedrich and Irene Johanna Virgolini},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2003},
  volume={44 10},
  pages={1547-55}
}
UNLABELLED Receptors for somatostatin (SST) (SSTR) are expressed on various tumor cells as well as on activated lymphocytes. Previous data have shown that (99m)Tc-P829 binds with high affinity to many different types of tumor cells as well as to leukocytes via the human hSSTR2, hSSTR3, and hSSTR5 target receptors. Consequently, (99m)Tc-P829 was successfully introduced as a peptide tracer for tumor imaging. In this study, we evaluated the orbital uptake of (99m)Tc-P829 in patients with active… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Diagnosis and Management of Graves’ Orbitopathy with Standardized Echography. Iowa City, IA: KC Ossoinig; 2000:1–13

  • KC Ossoinig
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…